• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Myriad Genetics, Inc. - Common Stock (NQ:MYGN)

    3.790 -0.120 (-3.07%)
    Streaming Delayed Price Updated: 3:42 PM EDT, May 22, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 670,181
    Open 3.880
    Bid (Size) 3.790 (300)
    Ask (Size) 3.800 (1,600)
    Prev. Close 3.910
    Today's Range 3.765 - 3.950
    52wk Range 3.530 - 8.590
    Shares Outstanding 93,500,000
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    1 Unprofitable Stock to Consider Right Now and 2 We Turn Down
    Unprofitable companies can burn through cash quickly, leaving investors exposed if they fail to turn things around. Without a clear path to profitability, th... 
    Via StockStory
    Topics Energy
    News headline image
    Actress Jackie Tohn Got Results Nobody Wants But They May Have Saved Her Life
    The Netflix star partners with Myriad Genetics to tell her BRCA1 story and why she wants everyone to know about hereditary cancer testing 
    From Myriad Genetics, Inc.
    Via GlobeNewswire

    Performance

    YTD
    -38.3%
    -38.3%
    1 Month
    -24.0%
    -24.0%
    3 Month
    -13.5%
    -13.5%
    6 Month
    -45.1%
    -45.1%
    1 Year
    -6.9%
    -6.9%

    More News

    Read More
    News headline image
    Myriad Genetics’s Q1 Earnings Call: Our Top 5 Analyst Questions
    Via StockStory
    Topics Earnings
    Myriad Genetics (NASDAQ:MYGN) Plunges 14% After Q1 Earnings Beat Revenue Estimates But Miss EPS ↗
    Via Chartmill
    Topics Earnings
    News headline image
    3 of Wall Street’s Favorite Stocks with Open Questions
    Via StockStory
    News headline image
    Myriad Genetics to Participate in Upcoming Investor Healthcare Conferences
    From Myriad Genetics, Inc.
    Via GlobeNewswire
    News headline image
    MYGN Q1 Deep Dive: Hereditary Cancer Strength, Launch Investments Pressure Margins
    Via StockStory
    News headline image
    Myriad Genetics (NASDAQ:MYGN) Misses Q1 CY2026 Sales Expectations, Stock Drops 16.2%
    Via StockStory
    News headline image
    Myriad Genetics Reports First Quarter 2026 Financial Results; Reiterates 2026 Financial Guidance Reflecting Ongoing Progress in the Cancer Care Continuum Business
    From Myriad Genetics, Inc.
    Via GlobeNewswire
    News headline image
    Myriad Genetics (MYGN) To Report Earnings Tomorrow: Here Is What To Expect
    Via StockStory
    Topics Artificial Intelligence
    News headline image
    Myriad Genetics National Survey: 88% of Patients with Depression and/or Anxiety Would Feel More Confident with a Personalized Mental Health Care Plan
    From Myriad Genetics, Inc.
    Via GlobeNewswire
    News headline image
    Myriad Genetics to Release First Quarter 2026 Financial Results on May 5, 2026
    From Myriad Genetics, Inc.
    Via GlobeNewswire
    News headline image
    3 Small-Cap Stocks We Think Twice About
    Via StockStory
    News headline image
    Myriad Genetics to Deliver Six Abstracts, Including Two Podiums, at AACR 2026
    From Myriad Genetics, Inc.
    Via GlobeNewswire
    News headline image
    Myriad Genetics Expands Access for MyChoice Test to Prostate Cancer Patients in Japan
    From Myriad Genetics, Inc.
    Via GlobeNewswire
    News headline image
    1 Cash-Burning Stock to Target This Week and 2 We Question
    Via StockStory
    News headline image
    Myriad Genetics Underscores Commitment to Cancer Care Continuum with New Data Presentations at SGO Annual Meeting
    From Myriad Genetics, Inc.
    Via GlobeNewswire
    News headline image
    Q4 Earnings Highlights: Myriad Genetics (NASDAQ:MYGN) Vs The Rest Of The Therapeutics Stocks
    Via StockStory
    Topics Artificial Intelligence
    News headline image
    3 Healthcare Stocks with Open Questions
    Via StockStory
    News headline image
    Elanco, Tandem Diabetes, Fortrea, Natera, and Myriad Genetics Shares Plummet, What You Need To Know
    Via StockStory
    Topics Government Stocks
    News headline image
    Myriad Genetics Receives FDA Approval of the MyChoice CDx Test as the Companion Diagnostic for Zejula (niraparib) for Patients with Ovarian Cancer
    From Myriad Genetics, Inc.
    Via GlobeNewswire
    News headline image
    2 High-Flying Stocks with Competitive Advantages and 1 We Brush Off
    Via StockStory
    News headline image
    Stocks making big moves yesterday: nLIGHT, Myriad Genetics, Vertex Pharmaceuticals, Nextpower, and Teladoc
    Via StockStory
    Topics Artificial Intelligence
    News headline image
    3 Reasons to Sell MYGN and 1 Stock to Buy Instead
    Via StockStory
    News headline image
    Myriad Genetics (MYGN) Shares Skyrocket, What You Need To Know
    Via StockStory
    Topics Artificial Intelligence Earnings

    Frequently Asked Questions

    Is Myriad Genetics, Inc. - Common Stock publicly traded?
    Yes, Myriad Genetics, Inc. - Common Stock is publicly traded.
    What exchange does Myriad Genetics, Inc. - Common Stock trade on?
    Myriad Genetics, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Myriad Genetics, Inc. - Common Stock?
    The ticker symbol for Myriad Genetics, Inc. - Common Stock is MYGN on the Nasdaq Stock Market
    What is the current price of Myriad Genetics, Inc. - Common Stock?
    The current price of Myriad Genetics, Inc. - Common Stock is 3.790
    When was Myriad Genetics, Inc. - Common Stock last traded?
    The last trade of Myriad Genetics, Inc. - Common Stock was at 05/22/26 03:42 PM ET
    What is the market capitalization of Myriad Genetics, Inc. - Common Stock?
    The market capitalization of Myriad Genetics, Inc. - Common Stock is 354.37M
    How many shares of Myriad Genetics, Inc. - Common Stock are outstanding?
    Myriad Genetics, Inc. - Common Stock has 354M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.